Skip to main content
Skip to content
Case File
d-26460House OversightOther

Ackrell Capital Chapter IV outlines U.S. Controlled Substances Act schedule definitions

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024705
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The passage merely recites public legal definitions and scheduling procedures for controlled substances, offering no specific actors, transactions, or novel allegations. It provides no actionable inve Describes the CSA scheduling process and the roles of DEA, DHHS, and FDA. Lists Schedule I substances, including marijuana. Explains exclusions for hemp and non‑marijuana cannabis products.

This document is from the House Oversight Committee Releases.

View Source Collection

Tags

dhhscsadeafdamarijuanahouse-oversightcontrolled-substances
Ask AI about this document

Search 264K+ documents with AI-powered analysis

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
ACKRELL CAPITAL CHAPTER IV U.S. Legal Landscape with the DEA. Any person that manufactures, distributes, dispenses or otherwise possesses a controlled substance in violation of the CSA is subject to civil and criminal penalties. The CSA schedules are numbered I to V. Schedule I substances are subject to the strictest controls, and Schedule V substances are subject to the least restrictive controls. A controlled substance is listed on a particular schedule according to four factors: (i) The substance’s potential for abuse. (ii) Whether the substance has a currently accepted medical use in treatment in the United States, (iii) Whether the substance is accepted as safe to use under medical supervision. (iv) The degree of physical and psychological dependence that may result from abuse of the substance. Upon enactment in 1970, the CSA assigned each controlled substance to a specific schedule. The U.S. Congress may legislate a controlled substance’s addition to or removal from a CSA schedule. The CSA also provides a regulatory framework for a substance to be added to or removed from a schedule; such change generally involves a recommendation by the U.S. Department of Health and Human Services (DHHS) and concurrence with that recommendation by the DEA. The U.S. Food and Drug Administration, an agency of the DHHS, is charged with making certain safety-related determinations used in DHHS scheduling recommendations. Schedule I controlled substances are those found by the U.S. Congress or the DEA and the DHHS to have a high potential for abuse, to have no currently accepted medical use in treatment in the United States and to have a lack of accepted safety for use under medical supervision. Current Schedule I sub- stances include marijuana, THC, heroin, ecstasy, LSD and peyote. Unlike Schedule II through Sched- ule V controlled substances, which can be prescribed by a doctor, the CSA does not allow prescriptions to be written for Schedule I controlled substances. Marijuana Marijuana has been a Schedule I controlled substance since enactment of the CSA in 1970. The CSA defines “marijuana” as all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof: the resin extracted from any part of such plant; and every compound, manufacture, salt, deriv- ative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. The parts and derivatives of the cannabis plant that are excluded from the CSA definition of marijuana have industrial uses and generally contain little or no THC. Non-marijuana cannabis products—commonly known as hemp products—including rope, clothing, animal feed and soap, are not subject to control under the CSA. The CSA does not restrict such non-marijuana products © 2017 Ackrell Capital, LLC | Member FINRA/SIPC 69

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.